4.7 Article

Nanocurcumin restores aberrant miRNA expression profile in multiple sclerosis, randomized, double-blind, placebo-controlled trial

Related references

Note: Only part of the references are listed.
Review Medicine, Research & Experimental

Epigenetic modifications and epigenetic based medication implementations of autoimmune diseases

Majid Ahmadi et al.

BIOMEDICINE & PHARMACOTHERAPY (2017)

Review Medicine, Research & Experimental

Multiple sclerosis: Therapeutic applications of advancing drug delivery systems

Sanam Dolati et al.

BIOMEDICINE & PHARMACOTHERAPY (2017)

Review Toxicology

IL-21 and IL-21 receptor in the immunopathogenesis of multiple sclerosis

Ghasem Ghalamfarsa et al.

JOURNAL OF IMMUNOTOXICOLOGY (2016)

Article Dentistry, Oral Surgery & Medicine

MicroRNA-340 Mediates Metabolic Shift in Oral Squamous Cell Carcinoma by Targeting Glucose Transporter-1

Ping Xu et al.

JOURNAL OF ORAL AND MAXILLOFACIAL SURGERY (2016)

Review Tropical Medicine

Multiple sclerosis: New insights and trends

Khaled Mohamed Mohamed Koriem

ASIAN PACIFIC JOURNAL OF TROPICAL BIOMEDICINE (2016)

Review Pharmacology & Pharmacy

Therapeutic Applications of Curcumin Nanoformulations

Murali M. Yallapu et al.

AAPS JOURNAL (2015)

Article Biochemistry & Molecular Biology

miR-340 inhibits glioblastoma cell proliferation by suppressing CDK6, cyclin-D1 and cyclin-D2

Xuesong Li et al.

BIOCHEMICAL AND BIOPHYSICAL RESEARCH COMMUNICATIONS (2015)

Meeting Abstract Oncology

TCRP1 gene promotes NIH/3T3 cell transformation by over-activating PDPK1 and Akt

Chengkun Wang et al.

CANCER RESEARCH (2015)

Review Clinical Neurology

miRNA in multiple sclerosis: search for novel biomarkers

Roopali Gandhi

MULTIPLE SCLEROSIS JOURNAL (2015)

Article Biotechnology & Applied Microbiology

Encapsulation of Curcumin in Diblock Copolymer Micelles for Cancer Therapy

Ali Mohammad Alizadeh et al.

BIOMED RESEARCH INTERNATIONAL (2015)

Review Clinical Neurology

miRNA in multiple sclerosis: search for novel biomarkers

Roopali Gandhi

MULTIPLE SCLEROSIS JOURNAL (2015)

Article Clinical Neurology

Natalizumab restores aberrant miRNA expression profile in multiple sclerosis and reveals a critical role for miR-20b

Jens Ingwersen et al.

ANNALS OF CLINICAL AND TRANSLATIONAL NEUROLOGY (2015)

Article Biochemistry & Molecular Biology

MicroRNA-155 negatively affects blood-brain barrier function during neuroinflammation

Miguel Alejandro Lopez-Ramirez et al.

FASEB JOURNAL (2014)

Article Biochemistry & Molecular Biology

MicroRNA Expression Changes during Interferon-Beta Treatment in the Peripheral Blood of Multiple Sclerosis Patients

Michael Hecker et al.

INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES (2013)

Article Neurosciences

miR-15a and 16-1 Are Downregulated in CD4+ T Cells of Multiple Sclerosis Relapsing Patients

Julio Cesar Cetrulo Lorenzi et al.

INTERNATIONAL JOURNAL OF NEUROSCIENCE (2012)

Review Immunology

The Role of Natural Killer Cells in Alzheimer's Disease

F. Jadidi-Niaragh et al.

SCANDINAVIAN JOURNAL OF IMMUNOLOGY (2012)

Article Clinical Neurology

Impaired neurosteroid synthesis in multiple sclerosis

Farshid Noorbakhsh et al.

BRAIN (2011)

Article Immunology

Curcumin has bright prospects for the treatment of multiple sclerosis

Lin Xie et al.

INTERNATIONAL IMMUNOPHARMACOLOGY (2011)

Review Immunology

MicroRNAs and Multiple Sclerosis

Kemal Ugur Tufekci et al.

AUTOIMMUNE DISEASES (2011)

Article Immunology

Altered miRNA expression in T regulatory cells in course of multiple sclerosis

Giuseppe De Santis et al.

JOURNAL OF NEUROIMMUNOLOGY (2010)